Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.41 |
| ▸ | USP2 | O75604 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL455182 | 1.00 | TSHR (0.46) | TSHRMAPTABCC4TRPA1USP2 | |
| SCHEMBL2164419 | 1.00 | — | — | |
| SCHEMBL2163541 | 1.00 | TSHR (0.46) | TSHRMAPTABCC4TRPA1USP2 | |
| SCHEMBL23111307 | 1.00 | TSHR (0.46) | TSHRMAPTABCC4TRPA1USP2 | |
| SCHEMBL2162669 | 0.97 | — | — | |
| SCHEMBL193970 | 0.89 | — | — | |
| SCHEMBL10770695 | 0.89 | TSHR (0.38) | TSHRMAPTABCC4TRPA1USP2 | |
| SCHEMBL10770693 | 0.89 | TSHR (0.38) | TSHRMAPTABCC4TRPA1USP2 | |
| SCHEMBL7292900 | 0.84 | USP2 (0.43) | TSHRMAPTABCC4TRPA1USP2 | |
| SCHEMBL21061587 | 0.80 | EP300 (0.37) | TSHRMAPTALDH1A1LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111093374-B | STABILIZED PROSTABILIZER-CONTAINING FORMULATIONS WITH LOW 2- (1-CHLOROCYCLOPROPYL) -1- (2-CHLOROPHENYL) -3- (1H-1,2, 4-TRIAZOL-1-YL) PROPAN-2-OL CONTENT | 拜耳股份公司 | 2022-06-10 | — | — | CN | claimed |
| CN-111093374-A | Stabilized formulation containing prothioconazole with low content of desulfurates | 拜耳股份公司 | 2020-05-01 | — | — | CN | claimed |
| EP-3638034-A1 | STABILISED FORMULATIONS CONTAINING PROTHIOCONAZOLE WITH A LOW 2-(1-CHLOROCYCLOPROPYL)-1-(2-CHLOROPHENYL)-3-(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL CONTENT | Bayer Aktiengesellschaft (DE) | 2020-04-22 | — | — | EP | claimed |
| US-20200093131-A1 | STABILISED FORMULATIONS CONTAINING PROTHIOCONAZOLE WITH A LOW 2-(1-CHLOROCYCLOPROPYL)-1-(2-CHLOROPHENYL)-3-(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL CONTENT | BAYER AKTIENGESELLSCHAFT (DE) | 2020-03-26 | — | — | US | claimed |
| EP-3157948-A1 | LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA | Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. (CZ) | 2017-04-26 | — | — | EP | claimed |
| US-20170044230-A1 | LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2017-02-16 | — | — | US | claimed |
| WO-2015197037-A1 | LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2015-12-30 | — | — | WO | claimed |
| EP-0442558-A1 | Fatty acid-specific lipase | UNILEVER N.V. (NL) | 1991-08-21 | — | — | EP | claimed |
| WO-2023203845-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-10-26 | — | — | WO | disclosed |
| WO-2023203837-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | 東京応化工業株式会社 | 2023-10-26 | — | — | WO | disclosed |
| CN-111093374-B | STABILIZED PROSTABILIZER-CONTAINING FORMULATIONS WITH LOW 2- (1-CHLOROCYCLOPROPYL) -1- (2-CHLOROPHENYL) -3- (1H-1,2, 4-TRIAZOL-1-YL) PROPAN-2-OL CONTENT | 拜耳股份公司 | 2022-06-10 | — | — | CN | disclosed |
| EP-3694324-A1 | ACTIVE INGREDIENT COMPOSITIONS COMPRISING N-ALKENOYL-N-ALKYLGLUCAMIDES AND THE USE THEREOF | Clariant International Ltd (CH) | 2020-08-19 | — | — | EP | disclosed |
| CN-111200933-A | Active ingredient compositions comprising N-enoyl-N-alkylglucamides and their use | 科莱恩国际有限公司 | 2020-05-26 | — | — | CN | disclosed |
| CN-111093374-A | Stabilized formulation containing prothioconazole with low content of desulfurates | 拜耳股份公司 | 2020-05-01 | — | — | CN | disclosed |
| US-4729989-A | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts | MERCK & CO., INC. (US) | 1988-03-08 | — | — | US | disclosed |
| US-4692441-A | B-LACTAM ANTIBIOTICS | MERCK & CO., INC. (US) | 1987-09-08 | — | — | US | disclosed |
| EP-0214898-A2 | Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities | MERCK & CO. INC. (US) | 1987-03-18 | — | — | EP | disclosed |
| EP-0206947-A2 | Pharmaceutical composition containing choline ester salts for enhancing gastrointestinal tract absorption | MERCK & CO. INC. (US) | 1986-12-30 | — | — | EP | disclosed |
| EP-0162764-A1 | Composition and method for enhancing absorption of drugs from gastrointestinal tract using acylcarnitines | MERCK & CO. INC. (US) | 1985-11-27 | — | — | EP | disclosed |
| US-4537772-A | Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines | MERCK & CO., INC. (US) | 1985-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200093131-A1 | STABILISED FORMULATIONS CONTAINING PROTHIOCONAZOLE WITH A LOW 2-(1-CHLOROCYCLOPROPYL)-1-(2-CHLOROPHENYL)-3-(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL CONTENT | CTRL, PIR, THOC2 | TSHR 3385/4885MAPT 1928/4885ABCC4 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.